Business news - New products

Filters

Capitalization

Sector

Add a keyword

Announcement Date

Since

Until

Hot News

ANDEAN SILVER LIMITED -11.00%

Andean Silver raises A$30 million placement at A$1.85 per share

SUNSTONE METALS LIMITED -13.64%

Sunstone Metals raises A$8 million via share placement

COBALT BLUE HOLDINGS LIMITED -11.43%

Cobalt Blue Holdings to raise A$5.3 million at A$0.09 per share

AUSTAL LIMITED -2.22%

Australia's treasurer says government will not extend electricity rebates

PARAGON CARE LIMITED -6.73%

Paragon Care appoints Brendon Pentland as CFO

CLINUVEL PHARMACEUTICALS LIMITED +3.41%

Clinuvel Pharmaceuticals expands Singapore R&D&I centre to pioneer next-generation peptide therapies

NATIONAL STORAGE REIT +2.01%

Brookfield, GIC Agree $4.5 Billion Deal for Australia's National Storage -- Update

ANSON RESOURCES LIMITED -8.57%

Anson Resources signs MoU lithium chloride offtake agreement with Nusano

NOVATTI GROUP LIMITED +6.25%

Novatti Group says AUDC's pre-Series A round raises A$5 million

BHP GROUP LIMITED -0.96%

Australian shares edge lower as mining, gold stocks lose shine

AUSTRALIAN VINTAGE LTD +5.00%

Australian Vintage executed distribution agreement with Invivo & Co Limited

DXN LIMITED +7.32%

Dxn secures A$2.1m of project work

GROWTHPOINT PROPERTIES AUSTRALIA -0.99%

Growthpoint Properties Australia appoints Melinda Ch'ng as CFO

DIGICO INFRASTRUCTURE REIT -0.99%

Digico Infrastructure REIT appoints Michael Juniper as CEO

TECHNOLOGY ONE LIMITED +0.47%

TechnologyOne responds to CTM related enquiries from shareholders

AMP LIMITED +0.28%

Amp launches constructor series in partnership with Dimensional and Southpeak

HORIZON MINERALS LIMITED 0.00%

Horizon Minerals says land use agreement signed with Marlinyu Ghoorlie Claim Group

Plus d''actualités qui impactent

Fulcrum Therapeutics, Inc. Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b Pioneer Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting FULC	07/12	CI
TScan Therapeutics Announces Positive Updated Data from the AlloHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition TCRX	07/12	CI
Pfizer Inc. Presents Results from the Phase 3 BASIS Study Evaluating HYMPAVZI for Adults and Adolescents PFE	07/12	CI
Protagonist Therapeutics, Inc. and Takeda Pharmaceutical Company Limited Present Longer-Term Data At ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera PTGX	07/12	CI
Nurix Therapeutics, Inc. Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia at the 67th American Society of Hematology Annual Meeting & Exposition NRIX	07/12	CI
Prelude Therapeutics Incorporated Presents Data at the 2025 ASH Annual Meeting from Its Myeloproliferative Neoplasm Programs PRLD	07/12	CI
Deciphera Pharmaceuticals Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemiaera at the 67th American Society of Hematology Annual Meeting DCPH	07/12	CI
Cogent Biosciences, Inc. Announces Complete Results from the Registration-Directed Part 2 of the Summit Clinical Trial of Bezuclastinib in Patients with Non Advanced Systemic Mastocytosis COGT	07/12	CI
Disc Medicine, Inc. Presents Positive Initial Data from Rally-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology Annual Meeting IRON	07/12	CI
Adaptive Biotechnologies Corporation Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ Data Driving Treatment Interventions at 2025 ASH Annual Meeting ADPT	07/12	CI
Ascentage Pharma Group International Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology Annual Meeting 6855	07/12	CI
Johnson & Johnson Announces Updated Results For CARVYKTI In Relapsed Or Refractory Multiple Myeloma JNJ	07/12	CI
Vertex Pharmaceuticals Incorporated Presents New Data on CASGEVY, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions VRTX	07/12	CI
Beam Therapeutics Inc. Reports Updated Data from BEACON Phase 1/2 Trial of Ristoglogene Autogetemcel (risto-cel) BEAM	07/12	CI
Arvinas, Inc. Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab At the 2025 American Society of Hematology Annual Meeting and Exposition ARVN	07/12	CI
Bicara Therapeutics Inc. Presents Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus BCAX	07/12	CI
Shanghai Junshi Biosciences Co., Ltd. Announces New and Promising Long-Term Survival Results from JUPITER-02 and JUPITER-06 at the European Society for Medical Oncology Asia Congress 2025 1877	06/12	CI
Johnson & Johnson's INLEXZO Delivers 74% Disease-Free Survival at One Year in Bcg-Unresponsive, High-Risk, Papillary-Only NMIBC JNJ	06/12	CI
Ocular Therapeutics, Inc. Intends to submit New Drug Application for its Product Candidate AXPAXLI OCUL	06/12	CI
Olympus Corporation Announces Voluntary Corrective Action for the Single-Use Ligating Device 7733	06/12	CI
Kymera Therapeutics, Inc. to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025 KYMR	06/12	CI
Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence ELV	06/12	CI
Amneal Pharmaceuticals, Inc. Announces Positive Interim Phase 4 Elevate-Pd Results with Crexont for Parkinson's Disease AMRX	06/12	CI
Kb Home Announces the Grand Opening of Its Newest Community in Highly Desirable Mill Creek, Washington KBH	06/12	CI
Kb Home Announces the Grand Opening of Mccormick Trails KBH	06/12	CI
Kuaishou Technology Launches Video 2.6 Model with "Simultaneous Audio-Visual Generation" Capability, Redefining AI Video Creation Workflow 1024	06/12	CI
Stoke Therapeutics, Inc. and Biogen Inc. Present Data That Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome STOK	06/12	CI
Jazz Pharmaceuticals plc to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex®? (Cannabidiol) Outcomes in Treatment-Resistant Epilepsies At the American Epilepsy Society 2025 Annual Meeting JAZZ	06/12	CI
EARNINGS & TRADING: Unicorn AIM VCT grapples with "constrained" market SBTX	06/12	AN
Rapport Therapeutics, Inc. Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219's Clinical Response in Patients with Focal Onset Seizures RAPP	06/12	CI
Lexicon Pharmaceuticals, Inc. Announces Clinical Data on Adipose Distribution in Non-Diabetic Patients to Be Presented At the 2025 Cardio Vascular Clinical Trialists Forum LXRX	06/12	CI
Owlet Launches TGA-Approved Dream Sock?? in Australia & New Zealand, Expanding International Footprint and Bringing Trusted Pediatric Health Monitoring to More Families Worldwide OWLT	06/12	CI
1Spatial wins contract to support National Underground Asset Register SPA	06/12	AN
Iofina signs deal with Western Midstream to support plant IOF	06/12	AN
RentGuarantor inks partnership with Jones Lang LaSalle RGG	06/12	AN
Abaxx Technologies Inc. to Launch Enwex United Kingdom Onshore Wind Futures on December 12, 2025 ABXX	06/12	CI
CG Oncology, Inc. Announces New Cretostimogene Grenadenorepvec Data Highlight Its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer CGON	06/12	CI
Zoetis Inc. Receives Health Canada Approval for Portela?? (Relfovetmab Injection) to Alleviate Pain Associated with Osteoarthritis in Cats ZTS	06/12	CI
Clerhp Announces Larimar City & Resort CLR	06/12	CI
Asahi Kasei Strengthens Long-Term Profitability by Phasing Out HMD Production as Part of Structural Reform 3407	06/12	CI
Blueprint Medicines Highlights Long-Term Clinical Benefit of Avapritinib Across Indolent and Advanced Systemic Mastocytosis At 2025 Ash Annual Meeting BPMC	06/12	CI
Astellas Pharma Inc. to Present New Data on XOSPATA (Gilteritinib) Across the FLT3m+ AML Disease Continuum At ASH 2025 Annual Meeting 4503	06/12	CI
Biomea Fusion, Inc. Presents Covid-111 Study Results At the 23Rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease BMEA	06/12	CI
Koryx Copper Inc. Provides Update on Zambia Projects with Definition of Drill Targets At Luanshya West and Completion of Regional Surface Geochemistry At Mpongwe KRY	06/12	CI
Shanghai Junshi Biosciences Co., Ltd. Announces Acceptance of the New Drug Application for Roconkibart Injection 1877	05/12	CI
Ocado to receive USD350 million payment from Kroger for CFC closures KR	05/12	AN
Avio signs new orders with MBDA worth over EUR35 million AVIO	05/12	AN
Aker BP and Equinor Announce New Discovery EQNR	05/12	CI
Leonardo Signs Contract with Italian Air Force for C-27J Logistic Support LDO	05/12	AN
ORIC Pharmaceuticals, Inc. Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025 ORIC	05/12	CI

No results for this search

Business news - New products

Filters

Popular Stocks

Hot News